Your browser doesn't support javascript.
loading
Autophagy Regulation of Metabolism Is Required for CD8+ T Cell Anti-tumor Immunity.
DeVorkin, Lindsay; Pavey, Nils; Carleton, Gillian; Comber, Alexandra; Ho, Cally; Lim, Junghyun; McNamara, Erin; Huang, Haochu; Kim, Paul; Zacharias, Lauren G; Mizushima, Noboru; Saitoh, Tatsuya; Akira, Shizuo; Beckham, Wayne; Lorzadeh, Alireza; Moksa, Michelle; Cao, Qi; Murthy, Aditya; Hirst, Martin; DeBerardinis, Ralph J; Lum, Julian J.
Afiliação
  • DeVorkin L; Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, BC, Canada.
  • Pavey N; Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, BC, Canada.
  • Carleton G; Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, BC, Canada; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada.
  • Comber A; Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, BC, Canada.
  • Ho C; Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, BC, Canada; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada.
  • Lim J; Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.
  • McNamara E; Department of In Vivo Pharmacology, Genentech, Inc., South San Francisco, CA, USA.
  • Huang H; Department of In Vivo Pharmacology, Genentech, Inc., South San Francisco, CA, USA.
  • Kim P; Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, BC, Canada; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada.
  • Zacharias LG; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Mizushima N; Department of Biochemistry and Molecular Biology, Graduate School and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Saitoh T; Division of Inflammation Biology, Institute for Enzyme Research, Tokushima University, Tokushima, Japan.
  • Akira S; Department of Host Defense, World Premier International Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan.
  • Beckham W; BC Cancer-Vancouver Island Centre, Medical Physics, Victoria, BC, Canada; Department of Physics and Astronomy, University of Victoria, Victoria, BC, Canada.
  • Lorzadeh A; Department of Microbiology and Immunology and Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada.
  • Moksa M; Department of Microbiology and Immunology and Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada.
  • Cao Q; Department of Microbiology and Immunology and Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada.
  • Murthy A; Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.
  • Hirst M; Department of Microbiology and Immunology and Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada; Canada's Michael Smith Genome Science Center, BC Cancer, Vancouver, BC, Canada.
  • DeBerardinis RJ; Children's Medical Center Research Institute, Department of Pediatrics and McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Lum JJ; Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, BC, Canada; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada. Electronic address: jjlum@bccancer.bc.ca.
Cell Rep ; 27(2): 502-513.e5, 2019 04 09.
Article em En | MEDLINE | ID: mdl-30970253
ABSTRACT
Autophagy is a cell survival process essential for the regulation of immune responses to infections. However, the role of T cell autophagy in anti-tumor immunity is less clear. Here, we demonstrate a cell-autonomous role for autophagy in the regulation of CD8+ T-cell-mediated control of tumors. Mice deficient for the essential autophagy genes Atg5, Atg14, or Atg16L1 display a dramatic impairment in the growth of syngeneic tumors. Moreover, T cells lacking Atg5 have a profound shift to an effector memory phenotype and produce greater amounts of interferon-γ (IFN-γ) and tumor necrosis factor α (TNF-α). Mechanistically, Atg5-/- CD8+ T cells exhibit enhanced glucose metabolism that results in alterations in histone methylation, increases in H3K4me3 density, and transcriptional upregulation of both metabolic and effector target genes. Nonetheless, glucose restriction is sufficient to suppress Atg5-dependent increases in effector function. Thus, autophagy-dependent changes in CD8+ T cell metabolism directly regulate anti-tumor immunity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Neoplasias Limite: Animals / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Neoplasias Limite: Animals / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá